Global Infection Control Market

Global Infection Control Market Size, Share, Growth Analysis, By Type(Equipment, Services), By End-User(Hospitals, Medical Device Companies) - Industry Forecast 2024-2031


Report ID: SQMIG35A2623 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 65 | Figures: 75

Global Infection Control Market News

  • In September 2021, through the Protecta Plus programme, Sodexo increased its collaboration with Ecolab in the US for the prevention of hospital-acquired infections. By utilizing Ecolab's Bioquell hydrogen peroxide vapor technology, this programme was developed to lower the risk of infection in hospitals and healthcare facilities.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Infection Control Market size was valued at USD 201.4 billion in 2019 and is poised to grow from USD 214 billion in 2023 to USD 359.6 billion by 2031, growing at a CAGR of 6.7% in the forecast period (2024-2031).

Major corporations, such as Advanced Sterilization Products, STERIS Corporation, and Cantel Medical Corporation, are widely implementing collaborative strategies in the competition, which accounts for their dominant market share. Adopting competitive strategies like mergers and acquisitions, new product development initiatives, and geographic expansion are top priorities for these players. As an illustration, 3M and Kimberly-Clark Health Care joined forces to co-develop and deliver surgical and infection prevention solutions using their respective expertise. '3M Company (US)', 'Ansell Limited', 'Becton, Dickinson and Company', 'Bio-Rad Laboratories, Inc.', 'Cantel Medical Corp.', 'Cardinal Health, Inc.', 'Getinge AB', 'Johnson & Johnson', 'Kimberly-Clark Corporation', 'Steris plc', 'Stryker Corporation', 'Danaher Corporation', 'Ecolab Inc.', 'Hill-Rom Holdings, Inc.', 'Molnlycke Health Care AB', 'Pal International Ltd.', 'Reckitt Benckiser Group plc', 'Semperit AG Holding', 'Sempermed', 'STERLING GLOVES SDN BHD'

A growing number of surgeries, hospital-acquired infections, and chronic illnesses among the aging population all benefit the infection control industry. 

Rise in the Number of Healthcare Facilities: The growing number of healthcare facilities around the world is what is driving the global infection control market. Increases in the incidence of hospital-acquired infections, surgical procedures requiring high-intensity infection prevention and control, the number of government awareness programmes aimed at ensuring high-level infection prevention, the geriatric population, and chronic disease cases like diabetes, obesity, cancer, heart disease, and respiratory disorders are all predicted to drive market growth.

With a revenue share of 37.9% in 2021, North America dominated the infection control market. The larger share seized by this region is thought to be due to a consistent number of strategic collaborations adopted by key market players to expand their product portfolio and infection control capabilities. Additionally, the established businesses' increased efforts to expand their presence throughout this region are to blame for North America's dominant market share.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Infection Control Market

Product ID: SQMIG35A2623

$5,300
BUY NOW GET FREE SAMPLE